BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30087457)

  • 1. Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues.
    Juskevicius D; Jucker D; Dietsche T; Perrina V; Rufle A; Ruiz C; Dirnhofer S; Tzankov A
    Lab Invest; 2018 Nov; 98(11):1487-1499. PubMed ID: 30087457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion.
    Wienand K; Chapuy B; Stewart C; Dunford AJ; Wu D; Kim J; Kamburov A; Wood TR; Cader FZ; Ducar MD; Thorner AR; Nag A; Heubeck AT; Buonopane MJ; Redd RA; Bojarczuk K; Lawton LN; Armand P; Rodig SJ; Fromm JR; Getz G; Shipp MA
    Blood Adv; 2019 Dec; 3(23):4065-4080. PubMed ID: 31816062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.
    Joos S; Menz CK; Wrobel G; Siebert R; Gesk S; Ohl S; Mechtersheimer G; Trümper L; Möller P; Lichter P; Barth TF
    Blood; 2002 Feb; 99(4):1381-7. PubMed ID: 11830490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.
    Barth TF; Martin-Subero JI; Joos S; Menz CK; Hasel C; Mechtersheimer G; Parwaresch RM; Lichter P; Siebert R; Möoller P
    Blood; 2003 May; 101(9):3681-6. PubMed ID: 12511414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.
    Reichel J; Chadburn A; Rubinstein PG; Giulino-Roth L; Tam W; Liu Y; Gaiolla R; Eng K; Brody J; Inghirami G; Carlo-Stella C; Santoro A; Rahal D; Totonchy J; Elemento O; Cesarman E; Roshal M
    Blood; 2015 Feb; 125(7):1061-72. PubMed ID: 25488972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.
    Salipante SJ; Adey A; Thomas A; Lee C; Liu YJ; Kumar A; Lewis AP; Wu D; Fromm JR; Shendure J
    Genes Chromosomes Cancer; 2016 Mar; 55(3):278-87. PubMed ID: 26650888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma.
    Slovak ML; Bedell V; Hsu YH; Estrine DB; Nowak NJ; Delioukina ML; Weiss LM; Smith DD; Forman SJ
    Clin Cancer Res; 2011 May; 17(10):3443-54. PubMed ID: 21385932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.
    Maura F; Ziccheddu B; Xiang JZ; Bhinder B; Rosiene J; Abascal F; Maclachlan KH; Eng KW; Uppal M; He F; Zhang W; Gao Q; Yellapantula VD; Trujillo-Alonso V; Park SI; Oberley MJ; Ruckdeschel E; Lim MS; Wertheim GB; Barth MJ; Horton TM; Derkach A; Kovach AE; Forlenza CJ; Zhang Y; Landgren O; Moskowitz CH; Cesarman E; Imielinski M; Elemento O; Roshal M; Giulino-Roth L
    Blood Cancer Discov; 2023 May; 4(3):208-227. PubMed ID: 36723991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
    Schmidt A; Schmitz R; Giefing M; Martin-Subero JI; Gesk S; Vater I; Massow A; Maggio E; Schneider M; Hansmann ML; Siebert R; Küppers R
    Genes Chromosomes Cancer; 2010 Sep; 49(9):803-9. PubMed ID: 20607853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.
    Gerhard-Hartmann E; Goergen H; Bröckelmann PJ; Mottok A; Steinmüller T; Grund J; Zamò A; Ben-Neriah S; Sasse S; Borchmann S; Fuchs M; Borchmann P; Reinke S; Engert A; Veldman J; Diepstra A; Klapper W; Rosenwald A
    Br J Haematol; 2022 Jan; 196(1):116-126. PubMed ID: 34520052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
    Lennerz JK; Hoffmann K; Bubolz AM; Lessel D; Welke C; Rüther N; Viardot A; Möller P
    Oncotarget; 2015 Oct; 6(30):29097-110. PubMed ID: 26336985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity.
    Giefing M; Winoto-Morbach S; Sosna J; Döring C; Klapper W; Küppers R; Böttcher S; Adam D; Siebert R; Schütze S
    PLoS One; 2013; 8(12):e84928. PubMed ID: 24376854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathobiology of classical Hodgkin lymphoma.
    Tzankov A; Dirnhofer S
    Pathobiology; 2006; 73(3):107-25. PubMed ID: 17085956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
    Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
    Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome.
    Steidl C; Telenius A; Shah SP; Farinha P; Barclay L; Boyle M; Connors JM; Horsman DE; Gascoyne RD
    Blood; 2010 Jul; 116(3):418-27. PubMed ID: 20339089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microenvironment in classical Hodgkin lymphoma].
    Mottok A
    Pathologe; 2020 May; 41(3):254-260. PubMed ID: 32239325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathway-focused gene expression profiles and immunohistochemistry detection identify contrasting association of caspase 3 (CASP3) expression with prognosis in pediatric classical Hodgkin lymphoma.
    Vera-Lozada G; Segges P; Stefanoff CG; Barros MHM; Niedobitek G; Hassan R
    Hematol Oncol; 2018 Oct; 36(4):663-670. PubMed ID: 29901224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.
    Roemer MG; Advani RH; Ligon AH; Natkunam Y; Redd RA; Homer H; Connelly CF; Sun HH; Daadi SE; Freeman GJ; Armand P; Chapuy B; de Jong D; Hoppe RT; Neuberg DS; Rodig SJ; Shipp MA
    J Clin Oncol; 2016 Aug; 34(23):2690-7. PubMed ID: 27069084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for immunophenotyping and purifying classical Hodgkin lymphoma cells from lymph nodes by flow cytometry and flow cytometric cell sorting.
    Fromm JR; Wood BL
    Methods; 2012 Jul; 57(3):368-75. PubMed ID: 22487184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.